Analyst Ratings For Medpace (NASDAQ:MEDP)
Today, Wells Fargo & Co lowered its price target on Medpace (NASDAQ:MEDP) to $35.00 per share.
Some recent analyst ratings include
- 2/27/2018-Credit Suisse Group Reiterated Rating of Outperform .
- 11/1/2017-William Blair was Downgraded by analysts at William Blair from a “Outperform ” rating to a ” Market Perform” rating.
- 10/17/2017-KeyCorp Reiterated Rating of Hold.
- 9/29/2017-Raymond James Financial initiated coverage with a Mkt Perform rating.
Recent Insider Trading Activity For Medpace (NASDAQ:MEDP)
Medpace (NASDAQ:MEDP) has insider ownership of 25.80% and institutional ownership of 20.71%.
- On 12/5/2017 Medpace Limited Partnership, Major Shareholder, sold 4,600,000 with an average share price of $30.16 per share and the total transaction amounting to $138,736,000.00.
- On 8/22/2017 Medpace Limited Partnership, Major Shareholder, sold 2,000,000 with an average share price of $30.27 per share and the total transaction amounting to $60,540,000.00.
- On 8/18/2016 August J Troendle, CEO, bought 10,000 with an average share price of $27.98 per share and the total transaction amounting to $279,800.00.
- On 8/17/2016 Susan E Burwig, Insider, bought 19,211 with an average share price of $29.21 per share and the total transaction amounting to $561,153.31.
- On 8/16/2016 August J Troendle, CEO, bought 869,565 with an average share price of $23.00 per share and the total transaction amounting to $19,999,995.00.
Recent Trading Activity for Medpace (NASDAQ:MEDP)
Shares of Medpace closed the previous trading session at 32.34 up +0.31 0.98% with 32.849998474121094 shares trading hands.